APOA5 抗体 (truncated)
Quick Overview for APOA5 抗体 (truncated) (ABIN2464012)
抗原
See all APOA5 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- truncated
-
免疫原
- Ni-NTA purified truncated recombinant human APOA5 expressed in E. Coli strain BL21 (DE3).
-
亚型
- IgG1
-
-
anti-Apolipoprotein A-V (APOA5) (AA 167-335) antibody
APOA5 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 167-335) antibodyAPOA5 适用: 人 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C11 unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 21-210) antibodyAPOA5 适用: 小鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 21-210) antibodyAPOA5 适用: 小鼠 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C1 unconjugated
anti-Apolipoprotein A-V (APOA5) antibodyAPOA5 适用: 人 ELISA, ICC 宿主: 小鼠 Multiclonal 2G1H11-HRP-1F1E8 unconjugated
anti-Apolipoprotein A-V (APOA5) antibodyAPOA5 适用: 人, 大鼠, 小鼠 WB, IF (p), IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 1-366) antibodyAPOA5 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (N-Term) antibodyAPOA5 适用: 人 WB, ELISA, ICC, IF 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 207-366) antibodyAPOA5 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 169-367) antibodyAPOA5 适用: 大鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Western Blot, ELISA.
Dilution:
Western Blot:1:500 - 1,000
ELISA:Determining optimal working dilutions by titration test.
-
限制
- 仅限研究用
-
-
-
缓冲液
- Ascitic fluid containing 0.03 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
储存条件
- -20 °C
-
储存方法
- Apoa5(bd) monoclonal antibody can be stored at -20 °C, stable for one year.
-
-
- APOA5 (Apolipoprotein A-V (APOA5))
-
别名
- Apoa5
-
背景
- Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serum triglyceride concentrations. An ApoA5 mouse knock-out model produced an approximately four fold increase in serum triglyc erides, whereas a knock-in model with human ApoA5 produced 50 70 % lower concentrations of mouse serum triglycerides. In addition, peroxisome proliferator-activated receptor-_ agonists, which are used clinically to lower serum triglyceride concentrations, cause increased ApoA5 mRNA expression. Recently, it was demonstrated that ApoA5 is present in human serum detected by polyclonal antibodies against both the NH2 and COOH termini, although at much lower concentration than other apolipoproteins.
-
基因ID
- 116519
-
UniProt
- Q6Q788
-
途径
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
抗原
-
